Cytox, a UK-based genetics prognosis platform spun out from University of Birmingham, has received £2.6m ($3.4m) in funding from a consortium featuring University of Oxford.
UK government-backed commercialisation vehicle Rainbow Seed Fund, managed by VC firm Midven, also took part as did local government-backed initiative GM&C Life Sciences Fund, overseen by VC firm Catapult Ventures.
Commitments were also secured from Perivoli Innovations, the intellectual property-focused arm of philanthropic office Perivoli Trust, and undisclosed backers.
Cytox is developing a genetics-based prognosis…